InvestorsHub Logo

12x

Followers 14
Posts 320
Boards Moderated 0
Alias Born 08/04/2022

12x

Re: Doc328 post# 409566

Sunday, 04/02/2023 11:09:50 AM

Sunday, April 02, 2023 11:09:50 AM

Post# of 459615
Good point. So 40M to run 1,000 patient p3/4 AD patient in US and 24M in AU. PD trial would be slightly cheaper. Anavex has the cash to complete both large AD and PD p3 trials. There is even less reason not to start the shorter duration PD p3 right away. PD provide the next best opportunity for a NDA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News